rs371964689
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000458500.5(RPL10):c.470C>T(p.Pro157Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000599 in 1,209,786 control chromosomes in the GnomAD database, including 3 homozygotes. There are 333 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 9/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000458500.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPL10 | NM_006013.5 | c.633C>T | p.Ala211= | synonymous_variant | 7/7 | ENST00000369817.7 | NP_006004.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPL10 | ENST00000369817.7 | c.633C>T | p.Ala211= | synonymous_variant | 7/7 | 5 | NM_006013.5 | ENSP00000358832 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000285 AC: 32AN: 112280Hom.: 0 Cov.: 23 AF XY: 0.000290 AC XY: 10AN XY: 34434
GnomAD3 exomes AF: 0.00179 AC: 303AN: 169742Hom.: 2 AF XY: 0.00274 AC XY: 159AN XY: 57948
GnomAD4 exome AF: 0.000631 AC: 693AN: 1097453Hom.: 3 Cov.: 31 AF XY: 0.000890 AC XY: 323AN XY: 362901
GnomAD4 genome AF: 0.000285 AC: 32AN: 112333Hom.: 0 Cov.: 23 AF XY: 0.000290 AC XY: 10AN XY: 34497
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 16, 2014 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at